Currently at 1 location in Israel for those Newly Diagnosed
Continue reading
MalignantNoMore
Safety and Efficacy Study in Recurrent Grade IV Glioma
Currently in 3 locations in the United States for those experiencing Recurrence or Progression
Continue readingStudy on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma (METT)
In 12 locations in South Korea for those experiencing Recurrence or Progression
Continue readingA Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Located in New York, NY, eligibility is Open
Continue readingMetformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
Based out of McGill University in Canada for Patients Newly Diagnosed
Continue readingPhase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Available at 2 medical centers in the U.S. for Pediatric patients experiencing Recurrence or Progression
Continue readingAccelerated Hypofractionated Intensity – Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (HBO-RT)
Available at 3 medical centers in Italy for those experiencing Recurrence
Continue readingRestricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors
Located in Guangdong, China for those experiencing Recurrence
Continue readingFeasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
Located in Cincinnati, Ohio for those Newly Diagnosed
Continue readingKetogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
Located in Los Angeles, California for those Newly Diagnosed
Continue reading